C. Russell

发表

Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study.

J. Schlom, W. Grizzle, E. Partridge, 1997, Gynecologic oncology.

Procedure guideline for diagnosis of renovascular hypertension

Göran Granerus, Eva V. Dubovsky, George N. Sfakianakis, 1998 .

Diagnosis of renovascular hypertension after renal transplantation.

C. Russell, E. Dubovsky, 1991, American journal of hypertension.

Measurement of glomerular filtration rate: single injection plasma clearance method without urine collection.

W. N. Tauxe, C. Russell, E. Dubovsky, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Gates method for GFR measurement.

C. Russell, E. Dubovsky, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Chronopotentiometric oxidation of substituted acetates in acetonitrile

C. Russell, 1976 .

Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibody.

S. Spencer, I. Brezovich, R. Meredith, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer.

J. Schlom, R. Meredith, R. Wheeler, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Quantitation of renal parenchymal retention of technetium-99m-MAG3 in renal transplants.

C. Russell, E. Dubovsky, Y. Li, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Measurement of renal function with technetium-99m-MAG3 in children and adults.

A. Taylor, C. Russell, E. Dubovsky, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Effect of arteriovenous difference in measuring renal function by single-injection plasma clearance: role of bolus.

C. Russell, E. Dubovsky, 1999, Nuclear medicine and biology.

Serum Glutamic-OxaloaceticTransami nase: Evaluation of a Coupled-ReactionEnzymeAssayby Meansof KineticTheory

C. Russell, 2004 .

Report of the Radionuclides in Nephrourology Committee for evaluation of transplanted kidney (review of techniques).

A. Taylor, G. Sfakianakis, C. Russell, 1999, Seminars in nuclear medicine.

Measurement of renal function with radionuclides.

C. Russell, E. Dubovsky, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Measurement of glomerular filtration rate using 99mTc-DTPA and the gamma camera: a comparison of methods

W. N. Tauxe, C. Russell, E. Dubovsky, 2004, European Journal of Nuclear Medicine.

Renal vascular transit time and tubular transit time dispersion for 99Tcm-MAG3

C. Russell, J. Scott, E. Dubovsky, 1997, Nuclear medicine communications.

Radionuclide evaluation of renal transplants.

C. Russell, E. Dubovsky, 1988, Seminars in nuclear medicine.

Measurementof Renal Function with Radionucides

C. Russell, E. Dubovsky, 1989 .

Procedure guideline for diagnosis of renovascular hypertension. Society of Nuclear Medicine.

M. Blaufox, A. Taylor, J. Fletcher, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49.

J. Schlom, W. Grizzle, E. Partridge, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A Bayesian 3-compartment model for 99mTc-MAG3 clearance.

C. Russell, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Technical Procedures for Use of the New Kidney Agent Technetium-99m MAG3™

C. Russell, E. Dubovsky, D. Young, 1991 .

Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-orthoiodohippurate.

C. Russell, E. Dubovsky, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Clinical use of a standard kit-preparation of radiolabeled monoclonal antibody 96.5 in the diagnostic imaging of metastatic melanoma.

M. Urist, R. Wheeler, A. Lobuglio, 1988, Journal of Clinical Oncology.

Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49.

J. Schlom, W. Grizzle, R. Meredith, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radionuclide evaluation of renal transplants.

B. Erbaş, C. Russell, E. Dubovsky, 1995, Seminars in nuclear medicine.

Quantitation of renal function with technetium-99m MAG3.

C. Russell, E. Dubovsky, M. Yester, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancer.

J. Schlom, R. Meredith, R. Wheeler, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants?

C. Russell, E. Dubovsky, M. Yester, 1990, Contributions to nephrology.

Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer.

J. Schlom, W. Grizzle, R. Meredith, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Substituent effects in the chronopotentiometric oxidation of ferrocene derivatives. Internal solvation of certain substituted ferricenium ions

C. Russell, D. Hall, 1967 .

Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer.

J. Schlom, W. Grizzle, R. Meredith, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Direct localization comparison of murine and chimeric B72.3 antibodies in patients with colon cancer.

J. Schlom, W. Grizzle, M. Urist, 1993, Human antibodies and hybridomas.

Prediction of urinary excretion of technetium-99m-MAG3.

A. Taylor, C. Russell, E. Dubovsky, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Reaction of Triethylamine at Platinum Anodes in Acetonitrile Solution; Solvent Background with Perchlorate Supporting Electrolyte.

C. Russell, 1963 .

Comparison of diagnostic and therapeutic doses of 131I-LYM-1 in patients with non-Hodgkin's lymphoma

R. Meredith, R. Wheeler, A. Lobuglio, 1993 .

Technetium pyrophosphate: a mixture?--Preparation of Tc(III) and Tc(IV) pyrophosphates and their comparative biologic properties.

C. Russell, R. Lindsay, J. E. Majerik, 1978, International journal of nuclear medicine and biology.

Radiochemical Purity of Technetium-99m-HMPAO Depends on Specific Activity

C. Russell, E. Dubovsky, H. Kahraman, 1995 .

Renal clearance of technetium-99m-MAG3: normal values.

C. Russell, E. Dubovsky, Y. Li, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Optimum sample times for single-injection, multisample renal clearance methods.

C. Russell, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Complexes of technetium with hydroxycarboxylic acids: gluconic, glucoheptonic, tartaric, and citric.

C. Russell, A. Speiser, 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Determination of net ionic charge on Tc-99m DTPA and Tc-99m EDTA by a column ion-exchange method.

C. Russell, A. G. Cash, R. Crittenden, 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Iminodiacetate complexes of technetium: an electrochemical study.

C. Russell, A. Speiser, 1982, The International journal of applied radiation and isotopes.

Electrochemistry of technetium

C. Russell, 1982 .

Oxidation state of technetium in bone scanning agents as determined at carrier concentration by amperometric titration.

C. Russell, A. G. Cash, 1979, The International journal of applied radiation and isotopes.

Complexes of technetium with pyrophosphate, etidronate, and medronate.

C. Russell, A. G. Cash, 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Polarographic reduction of pertechnetate

C. Russell, A. G. Cash, 1978 .

Analysis of Products from the Electrolytic Oxidation of Acetate Ion in Acetonitrile

F. Anson, C. Russell, 1961 .

Tracer electrochemistry of pertechnetate: Chelation of 99mTc by EDTA after controlled-potential reduction at mercury and platinum cathodes

C. Russell, J. E. Majerik, 1978 .

The 125I thyroid scan: clinicopathologic correlation.

J. Waisman, C. Russell, M. Webber, 1975, International journal of nuclear medicine and biology.

Mean ionic charge on two components of technetium pyrophosphate prepared using stannous chloride.

C. Russell, P. G. Bischoff, 1984, The International journal of applied radiation and isotopes.

Quantitation of renal function with glomerular and tubular agents.

C. Russell, E. Dubovsky, 1982, Seminars in nuclear medicine.

Determination of pertechnetate in radiopharmaceuticals by high-pressure liquid thin-layer and paper chromatography

C. Russell, J. E. Majerik, 1979 .

Acid-base metabolism and the proton condition.

C. Russell, 1968, Journal of theoretical biology.

Advances in radionuclide evaluation of urinary tract obstruction

C. Russell, E. Dubovsky, 1998, Abdominal Imaging.

Report of the Radionuclides in Nephrourology Committee on renal clearance.

M D Blaufox, M. Blaufox, A. Taylor, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Acute response to acid-base stress in the dog.

E. DeLand, C. Russell, J. V. Maloney, 1972, The American journal of physiology.

Estimation of technetium-99m-MAG3 plasma clearance in adults from one or two blood samples.

D. Eshima, A. Taylor, C. Russell, 1989, Journal of Nuclear Medicine.

Estimation of ERPF in adults from plasma clearance of 131I-hippuran using a single injection and one or two blood samples.

C. Russell, J. Scott, E. Dubovsky, 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Consensus report on ACE inhibitor renography for detecting renovascular hypertension. Radionuclides in Nephrourology Group. Consensus Group on ACEI Renography.

A. Taylor, J. Nally, G. Sfakianakis, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Technique of Scanning for Meckel's Diverticulum

C. Russell, E. Dubovsky, W. Bridger, 1978, Clinical nuclear medicine.

Prediction of renal transplant survival from early postoperative radioisotope studies.

R. Gaston, C. Russell, A. Diethelm, 2000, Journal of Nuclear Medicine.

Renal transplant hypertension caused by iliac artery stenosis.

F. Keller, C. Russell, A. Diethelm, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Quantitation of renal function using MAG3.

C. Russell, E. Dubovsky, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A Bayesian regression model for plasma clearance.

C. Russell, E. Dubovsky, Andrew Taylor, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Effect of human immune response on repeat courses of 131-chimeric B72.3 antibody therapy

R. Meredith, R. Wheeler, A. Lobuglio, 1993 .

Comparison of two mouse/human chimeric antibodies in patients with metastatic colon cancer

S. Spencer, I. Brezovich, R. Meredith, 1992 .

Demonstration of a chemodectoma by perfusion scanning: case report.

C. Russell, E. Dubovsky, H. P. Jander, 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Interpretation of totally irreversible chronopotentiometric waves

C. Russell, J. M. Peterson, 1963 .

Reverse-Current and Current-Cessation Chronopotentiometry with a Two-Component System.

F. Anson, C. Russell, W. E. Palke, 1962 .

Polarographic reduction of pertechnetate

C. Russell, A. G. Cash, 1978 .

Carrier electrochemistry of pertechnetate: application to radiopharmaceutical labelling by controlled potential electrolysis at chemically inert electrodes.

C. Russell, 1977, The International journal of applied radiation and isotopes.

Techniques for measuring renal transit time

C. Russell, E. Dubovsky, M. Japanwalla, 1995, European Journal of Nuclear Medicine.

Measurement of Renal Parenchymal Transit Time of 99mTc-MAG3 Using Factor Analysis

C D Russell, M V Yester, C. Russell, 1990, Nuklearmedizin.

Fitting linear compartmental models by a matrix diagonalization method

C D Russell, C. Russell, 2001, Nuclear medicine communications.

Comparison of technetium-99m MAG3 with iodine-131 hippuran by a simultaneous dual channel technique.

C. Russell, E. Dubovsky, M. Yester, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Quality control of Tc-99m DTPA for measurement of glomerular filtration: concise communication.

W. N. Tauxe, C. Russell, E. Dubovsky, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Error analysis of one sample clearance methods

Eva V. Dubovsky, Charles D. Russell, C. Russell, 2004, European Journal of Nuclear Medicine.

A single-injection, two-sample method for measuring renal 99mTc-MAG3 clearance in both children and adults.

D. Eshima, A. Taylor, C. Russell, 1995, Nuclear medicine and biology.

Complex Ions. V. The Magnetic Moments of Some Complex Ions of Nickel and Copper1

G. Cooper, W. Vosburgh, C. Russell, 1943 .

Quality control of technetium-99m DTPA: correlation of analytic tests with in vivo protein binding in man.

C. Russell, J. Scott, K. Rowell, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Relative Permeability To Gas

W. J. Leas, J. H. Jenks, Charles D. Russell, 1950 .